Xtant Medical Holdings, Inc. (XTNT) › Cash & EquivalentsXtant Medical Holdings, Inc. (XTNT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $54.2K2010: $327.5K2011: $751.1K2012: $4.93M2013: $3.05M2014: $4.47M2015: $6.37M2016: $2.58M2017: $2.86M2018: $6.80M2019: $5.24M2020: $2.34M2021: $18.24M2022: $20.30M2023: $5.71M2024: $6.20M2025: $17.05M$17.05M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$17.05M+175.1%2024$6.20M+8.5%2023$5.71M-71.8%2022$20.30M+11.3%2021$18.24M+679.3%2020$2.34M-55.3%2019$5.24M-23.0%2018$6.80M+138.0%2017$2.86M+10.8%2016$2.58M-59.5%2015$6.37M+42.5%2014$4.47M+46.7%2013$3.05M-38.2%2012$4.93M+555.8%2011$751.1K+129.4%2010$327.5K+504.7%2009$54.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share